Viewing Study NCT00334750


Ignite Creation Date: 2025-12-24 @ 4:49 PM
Ignite Modification Date: 2025-12-29 @ 3:53 AM
Study NCT ID: NCT00334750
Status: COMPLETED
Last Update Posted: 2021-02-02
First Post: 2006-06-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Distribution of Risk Factors in Ocular Hypertension and Open-Angle Glaucoma Patients in Canada
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module